Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals mixed signals: while Crop Care revenue and gross profit grew significantly, overall consolidated gross profit and adjusted EBITDA decreased due to input price deflation. The Q&A section highlights uncertainties, such as the impact of safrinha corn sales and farmer bankruptcies. Despite some positive outlooks, like Crop Care's growth and sales staff expansion, the lack of clear guidance and declining financial metrics suggest a neutral sentiment. Without market cap data, the stock reaction is uncertain, but the mixed results and cautious outlook likely lead to a neutral price movement.
Revenue $618 million, a 1% increase year-over-year, driven by volume growth and market share gains offsetting input price deflation.
Consolidated Gross Profit $103 million, a 17% decrease year-over-year, primarily due to steep price declines in crop protection and fertilizers.
Adjusted EBITDA $40 million, a 48% decrease year-over-year, influenced by gross margin compression.
Adjusted Net Profit $2.6 million, a decline of $34.8 million year-over-year, driven by lower adjusted EBITDA and higher financial costs.
Gross Margin 16.7%, a contraction of 360 basis points year-over-year, mainly due to price declines in crop protection and fertilizers.
Adjusted EBITDA Margin 6.5%, a contraction of 48.8% year-over-year, primarily influenced by gross margin compression.
SG&A to Sales Ratio 11.3%, an increase of 300 basis points year-over-year, due to higher investments and increased allowance for expected credit losses.
Brazil Ag Retail Gross Margin 13.9%, a contraction of 510 basis points year-over-year, but improved sequentially from the first quarter.
Latam Ag Retail Gross Margin 17.8%, a decline of 230 basis points year-over-year, driven by compression in crop protection and fertilizer distribution margins.
Crop Care Gross Margin 35.3%, a decline of 160 basis points year-over-year, primarily due to unfavorable mix effects.
Crop Care Revenue Growth: Crop Care recorded revenue of $72.8 million in Q2 2024, a 26% increase year-over-year, driven by strong performance in specialty fertilizers.
Integra Product Performance: The specialty fertilizer product Integra showed a remarkable 55% increase in sales.
Cromo Química Acquisition: The acquisition of Cromo Química contributed 5% to Crop Care segment revenue.
Brazil Ag Retail Volume Growth: In Brazil Ag Retail, crop protection, fertilizers, and specialty products volumes grew 46%, 63%, and 29% year-over-year, respectively.
Market Share Gains: Lavoro gained market share in Brazil, driven by strong execution from local commercial teams.
Colombian Operation Performance: Lavoro's Colombian operation showed notable gains in market share despite challenges.
RTV Hiring: Lavoro concluded Q2 with over 1,040 RTVs in Brazil, a 25% increase from Q1.
SG&A Increase: SG&A excluding depreciation increased by 300 basis points to 11.3% due to higher investments in hiring.
Sales Team Investments: Lavoro is making significant investments to enhance its sales teams, positioning itself for market recovery.
Market Outlook: Lavoro anticipates a 25% decrease in Brazil's retail input market for the 2023-2024 crop year.
Input Price Deflation: The company is experiencing significant input price deflation in crop protection and fertilizers, which has adversely impacted gross margins and overall profitability.
Market Environment: The agricultural retail market in Brazil is highly competitive, with pressures from both local and international players affecting pricing and market share.
El Nino Impact: Adverse weather conditions, specifically the effects of El Nino, have negatively influenced demand for biological products and altered farmers' purchasing behaviors.
Supply Chain Challenges: The company faces challenges related to supply chain dynamics, including the timing of farmers' orders and the lag between purchasing inputs and selling them.
Economic Factors: The overall economic environment, including inflationary pressures and fluctuating currency values, poses risks to revenue and profitability.
Credit Risk: Increased allowance for expected credit losses due to the impact of El Nino on payment schedules from farmer clients, indicating potential credit risk.
Operational Costs: Higher SG&A expenses due to investments in hiring new sales representatives, which have yet to yield expected sales contributions.
Market Share Gains: Lavoro achieved significant market share gains in Brazil Ag Retail, with crop protection, fertilizers, and specialty products volumes growing 46%, 63%, and 29% year-over-year.
Hiring of RTVs: The company increased its seasonal technical sales representatives (RTVs) to over 1,040, a 25% increase from the previous quarter, with expected positive contributions in the next fiscal year.
Crop Care Performance: Crop Care segment saw revenues and gross profits grow over 20% year-over-year, indicating strong performance despite market challenges.
Investment in Sales Teams: Lavoro is making substantial investments to enhance its sales teams, positioning itself to capitalize on anticipated market recovery.
Revenue Outlook: Lavoro maintains its financial outlook, expecting a 25% decrease in Brazil's retail input market for the 2023-2024 crop year.
Gross Margin Recovery: The company anticipates a gradual recovery in gross margins as local input prices stabilize and higher-cost inventory cycles are cycled through.
Future Market Conditions: The company is optimistic about the market landscape, believing it has the potential to accelerate transformation within the agricultural sector in Brazil and South America.
Adjusted EBITDA: Adjusted EBITDA for Q2 2024 was $40 million, down 48% year-over-year, reflecting ongoing margin pressures.
Share Buyback Program: None
The earnings call reveals several negative aspects: increased net loss, credit access challenges, and reduced gross margins. Although revenue increased, significant margin compression and higher finance costs overshadow these gains. The Q&A section indicates concerns about credit lines and unclear management responses, adding to the negative sentiment. With no share repurchase plan and a focus on operational efficiency due to market challenges, the outlook remains bleak. Consequently, the stock price is likely to experience a negative reaction in the coming weeks.
The earnings call highlights significant challenges: decreased revenue in key segments, margin pressures, and a net loss despite some growth in specific areas like grains and Crop Care. The Q&A reveals uncertainties in future revenue and no expectation of further pricing cuts, which could stabilize margins. However, the overall sentiment remains negative due to ongoing financial pressures, adverse market conditions, and a weak adjusted EBITDA. Without a market cap, the stock's reaction is uncertain, but the negative financial trends suggest a likely decline in stock price.
The earnings call reveals mixed signals: while Crop Care revenue and gross profit grew significantly, overall consolidated gross profit and adjusted EBITDA decreased due to input price deflation. The Q&A section highlights uncertainties, such as the impact of safrinha corn sales and farmer bankruptcies. Despite some positive outlooks, like Crop Care's growth and sales staff expansion, the lack of clear guidance and declining financial metrics suggest a neutral sentiment. Without market cap data, the stock reaction is uncertain, but the mixed results and cautious outlook likely lead to a neutral price movement.
The company reported strong financial performance with significant revenue and EBITDA growth, particularly in the Crop Care segment. Despite challenges like postponed acquisitions and regulatory hurdles, the company projects continued revenue growth and has strategies to mitigate pricing headwinds. Positive factors such as increased gross profit and margin expansion, alongside optimistic guidance for FY 2024, outweigh the risks. The earnings call Q&A also highlights robust demand and growth potential, suggesting a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.